Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.

Dallas skyline lights up with breakthrough GLP-1 ad from Fridays IRVINE, Calif., /PRNewswire/ -- Fridays, the wellness company redefining ...

A new survey has revealed that a staggering 94 per cent of healthcare professionals doubt the NHS can provide safe, ongoing ...

Danone company Kate Farms tapped its medical nutrition expertise to craft a high-protein shake for everyday wellness. Here’s ...

Most policies still exclude weight-loss medications under general exclusions unless they are part of the treatment of a ...

The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...

The findings from the Kinsey Institute and DatingAdvice come as 6.7 million Americans have been reported as using GLP-1 medications ...

GLP-1s double as not only a weight loss drug but also a dating confidence booster. Fifty-nine percent of surveyed GLP-1 users ...

Battered by multiple years of high health care costs, employers are planning to shift more of the expense to workers in 2026.

According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spend.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...